Cargando…
Polypharmacy and potential drug–drug interactions for people with HIV in the UK from the Climate‐HIV database
OBJECTIVES: People with HIV (PWHIV) are likely to need therapies for comorbidities as they age. We assessed risk of drug–drug interactions (DDIs) in PWHIV. METHODS: The Climate‐HIV electronic recording system was used to cross‐sectionally analyse records from PWHIV aged ≥ 18 years attending four UK...
Autores principales: | Okoli, C, Schwenk, A, Radford, M, Myland, M, Taylor, S, Darley, A, Barnes, J, Fox, A, Grimson, F, Reeves, I, Munshi, S, Croucher, A, Boxall, N, Benn, P, Paice, A, van Wyk, J, Khoo, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497154/ https://www.ncbi.nlm.nih.gov/pubmed/32671950 http://dx.doi.org/10.1111/hiv.12879 |
Ejemplares similares
-
Using Climate-HIV to describe real-world clinical outcomes for people living with HIV taking dolutegravir-based regimens
por: Okoli, Chinyere, et al.
Publicado: (2021) -
Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV
por: Courlet, Perrine, et al.
Publicado: (2019) -
POLYPHARMACY VERSUS DRUG COMBINATIONS
por: Agarwal, A.K.
Publicado: (1991) -
The Next Therapeutic Challenge in HIV: Polypharmacy
por: Edelman, E. Jennifer, et al.
Publicado: (2013) -
Relationship Between Polypharmacy and Quality of Life Among People in 24 Countries Living With HIV
por: Okoli, Chinyere, et al.
Publicado: (2020)